US IEEPA Tariff Refund Program Launch Operational Update and Market Implications General Motors Company GM Q1 2026 Earnings Preview Key Metrics Peer Benchmarks and Investor Expectations AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks